StreetInsider.com Pre-Open Movers:

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) 65% HIGHER; announced positive top-line results from its Phase II schizophrenia ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE